{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:01:44Z","timestamp":1788307304067,"version":"build-2803163510"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2009,10,30]],"date-time":"2009-10-30T00:00:00Z","timestamp":1256860800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0007670","type":"journal-article","created":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T21:32:56Z","timestamp":1256851976000},"page":"e7670","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":40,"title":["Serum S100A6 Concentration Predicts Peritoneal Tumor Burden in Mice with Epithelial Ovarian Cancer and Is Associated with Advanced Stage in Patients"],"prefix":"10.1371","volume":"4","author":[{"given":"Bih-Rong","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley B.","family":"Hoover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Meani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer B.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth I.","family":"Spehalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John I.","family":"Risinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Gregory","family":"Alvord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio A.","family":"Qui\u00f1ones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Belluco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Martella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Campagnutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Ravaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Ming","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Woolard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Pecorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance A.","family":"Liotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel F.","family":"Petricoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Mark","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,10,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008.","volume":"58","author":"A Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/jnci\/95.2.94","article-title":"Early-stage ovarian cancer: to treat or not to treat.","volume":"95","author":"RC Young","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.","volume":"164","author":"M Shih Ie","year":"2004","journal-title":"Am J Pathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary.","volume":"351","author":"SA Cannistra","year":"2004","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0090-8258(85)90015-0","article-title":"Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma.","volume":"22","author":"RC Bast Jr","year":"1985","journal-title":"Gynecol Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0028-2243(85)90130-3","article-title":"Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinoma.","volume":"19","author":"RC Bast Jr","year":"1985","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1021\/pr070041v","article-title":"Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers.","volume":"6","author":"TI Williams","year":"2007","journal-title":"J Proteome Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ajog.2008.04.009","article-title":"The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?","volume":"199","author":"V Nossov","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jssc.200800622","article-title":"Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.","volume":"32","author":"FE Ahmed","year":"2009","journal-title":"J Sep Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-59745-493-3_19","article-title":"Proteomic global profiling for cancer biomarker discovery.","volume":"492","author":"V Faca","year":"2009","journal-title":"Methods Mol Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.chroma.2006.11.054","article-title":"Sample preparation for serum\/plasma profiling and biomarker identification by mass spectrometry.","volume":"1153","author":"JL Luque-Garcia","year":"2007","journal-title":"J Chromatogr A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrc2011","article-title":"The blood peptidome: a higher dimension of information content for cancer biomarker discovery.","volume":"6","author":"EF Petricoin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"35035","DOI":"10.1074\/jbc.M205854200","article-title":"Albumin binding as a general strategy for improving the pharmacokinetics of proteins.","volume":"277","author":"MS Dennis","year":"2002","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1042\/bj3120725","article-title":"Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo.","volume":"312 ( Pt3)","author":"P Kurtzhals","year":"1995","journal-title":"Biochem J"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0022-3565(25)12853-X","article-title":"Extended in vivo half-life of human soluble complement receptor type 1 fused to a serum albumin-binding receptor.","volume":"277","author":"SC Makrides","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1021\/pr800210b","article-title":"A mouse model repository for cancer biomarker discovery.","volume":"7","author":"KS Kelly-Spratt","year":"2008","journal-title":"J Proteome Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jasms.2005.02.005","article-title":"Quantitative analysis of the low molecular weight serum proteome using 18O stable isotope labeling in a lung tumor xenograft mouse model.","volume":"16","author":"BL Hood","year":"2005","journal-title":"J Am Soc Mass Spectrom"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/pmic.200400785","article-title":"Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human.","volume":"4","author":"HF Juan","year":"2004","journal-title":"Proteomics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/pmic.200500151","article-title":"Proteomics of xenografted human breast cancer indicates novel targets related to tamoxifen resistance.","volume":"6","author":"V Besada","year":"2006","journal-title":"Proteomics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1021\/pr060124w","article-title":"Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice.","volume":"5","author":"M Rantalainen","year":"2006","journal-title":"J Proteome Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/mc.20315","article-title":"Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).","volume":"46","author":"M Zietarska","year":"2007","journal-title":"Mol Carcinog"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2559.2005.02097.x","article-title":"Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers.","volume":"46","author":"SS Cross","year":"2005","journal-title":"Histopathology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000090240","article-title":"S100A6 and CacyBP\/SIP - two proteins discovered in ehrlich ascites tumor cells that are potentially involved in the degradation of beta-catenin.","volume":"52","author":"A Filipek","year":"2006","journal-title":"Chemotherapy"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0167-4889(99)00058-0","article-title":"Functional roles of S100 proteins, calcium-binding proteins of the EF-hand type.","volume":"1450","author":"R Donato","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbrc.2007.10.082","article-title":"Calcium, troponin, calmodulin, S100 proteins: from myocardial basics to new therapeutic strategies.","volume":"369","author":"MC Schaub","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0968-0004(96)80167-8","article-title":"The S100 family of EF-hand calcium-binding proteins: functions and pathology.","volume":"21","author":"BW Schafer","year":"1996","journal-title":"Trends Biochem Sci"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","article-title":"S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles.","volume":"33","author":"R Donato","year":"2001","journal-title":"Int J Biochem Cell Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0014-4827(92)90191-A","article-title":"Calcyclin as a marker of human epithelial cells and fibroblasts.","volume":"200","author":"J Kuznicki","year":"1992","journal-title":"Exp Cell Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1158\/0008-5472.CAN-04-4311","article-title":"High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.","volume":"65","author":"D Vimalachandran","year":"2005","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/mc.20193","article-title":"Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.","volume":"45","author":"LM Brown","year":"2006","journal-title":"Mol Carcinog"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2559.2005.02137.x","article-title":"Expression of S100A2 and S100A6 in thyroid carcinomas.","volume":"46","author":"Y Ito","year":"2005","journal-title":"Histopathology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/path.1418","article-title":"Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent.","volume":"201","author":"T Crnogorac-Jurcevic","year":"2003","journal-title":"J Pathol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1158\/1078-0432.CCR-05-0714","article-title":"The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target.","volume":"11","author":"K Ohuchida","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1054\/bjoc.2000.1356","article-title":"Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma.","volume":"83","author":"K Komatsu","year":"2000","journal-title":"Br J Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.lungcan.2008.06.003","article-title":"Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.","volume":"63","author":"L De Petris","year":"2009","journal-title":"Lung Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1055-9965.EPI-06-0157","article-title":"S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples.","volume":"16","author":"K Ohuchida","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.canlet.2005.02.015","article-title":"Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma.","volume":"229","author":"HH Luu","year":"2005","journal-title":"Cancer Lett"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"200s","DOI":"10.1200\/JCO.2003.01.068","article-title":"Status of tumor markers in ovarian cancer screening.","volume":"21","author":"RC Bast Jr","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.ejca.2004.05.021","article-title":"Biomarkers of ovarian tumours.","volume":"40","author":"AV Rapkiewicz","year":"2004","journal-title":"Eur J Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4161\/cc.8.5.7848","article-title":"Epithelial ovarian cancer: focus on genetics and animal models.","volume":"8","author":"W Shan","year":"2009","journal-title":"Cell Cycle"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","article-title":"Use of proteomic patterns in serum to identify ovarian cancer.","volume":"359","author":"EF Petricoin","year":"2002","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2741\/3364","article-title":"Ovarian cancer: pathology, biology, and disease models.","volume":"14","author":"DG Rosen","year":"2009","journal-title":"Front Biosci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/pmic.200700951","article-title":"Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancer.","volume":"8","author":"T Grote","year":"2008","journal-title":"Proteomics"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-5956-7-15","article-title":"Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker.","volume":"7","author":"A Aguilar-Mahecha","year":"2009","journal-title":"Proteome Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/prca.200600618","article-title":"A method for the selevtive isolation and enrichment of carrier protein-bound low-molecular weight proteins and peptides in the blood.","volume":"1","author":"S Camerini","year":"2007","journal-title":"Proteomics Clin Appl"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1177\/0192623308327120","article-title":"Altered {beta}-catenin accumulation in hepatocellular carcinomas of diethylnitrosamine-exposed rhesus macaques.","volume":"36","author":"BR Wei","year":"2008","journal-title":"Toxicol Pathol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/pros.20386","article-title":"Characterization of an antibody that can detect the Kai1\/CD82 murine metastasis suppressor.","volume":"66","author":"MC Custer","year":"2006","journal-title":"Prostate"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0022-1759(93)90082-I","article-title":"Determining confidence limits for drug potency in immunoassay.","volume":"157","author":"WG Alvord","year":"1993","journal-title":"J Immunol Methods"},{"key":"ref49","first-page":"E97","article-title":"Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.","volume":"235","author":"A DeLean","year":"1978","journal-title":"Am J Physiol"},{"key":"ref50","doi-asserted-by":"crossref","DOI":"10.1002\/9781118625590","article-title":"Applied Regression Analysis.","author":"NR Draper","year":"1998"},{"key":"ref51","article-title":"SAS System for Mixed Models: SAS Institute, Inc.","author":"RC Littell","year":"1996"},{"key":"ref52","article-title":"Analysis of Messy Data.","author":"GA Milliken","year":"2009"},{"key":"ref53","article-title":"SAS\/STAT software. 9.1.3 ed.","year":"2002"},{"key":"ref54","article-title":"S-PLUS\u00ae 7.0 for Windows.","year":"2005"},{"key":"ref55","article-title":"R: A language and environment for statistical computing.","author":"RDC Team","year":"2008"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/sj.onc.1204265","article-title":"Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front.","volume":"20","author":"CP Paweletz","year":"2001","journal-title":"Oncogene"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0007670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:24:34Z","timestamp":1739406274000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0007670"}},"subtitle":[],"editor":[{"given":"Irene Oi-Lin","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,30]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2009,10,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0007670","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,30]]}}}